Coffee flavor is greatly associated with its volatile compounds, and the lack of these compounds can decrease the quality of ...
New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.
Formycon AG (FSE: FYB, Prime Standard) and MS Pharma jointly announce that they have entered into an exclusive licensing and ...
‘Chief Medical Officer’s Annual Report 2025: Infections’ was published at 15:00 UK time on Thursday the 4th of December 2025. Prof Andrew Morris: Andrew is the President of the Academy of Medical ...
The Granulated Tapioca Market is estimated to be valued at USD 0.8 billion in 2025 and is projected to reach USD 1.3 billion ...
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, and ...
Antibody Specificity Testing Market is expected to Reach to US $1.9 Bn by 2035, Driven by Rising Demand for Personalized ...
Gordon Freeman, Harvard Medical School professor of medicine at Dana-Farber Cancer Institute, and Arlene Sharpe, the ...
Initiated prestIgE Phase 2b trial of ozureprubart in food allergy - Announced positive topline data from Phase 2 trial in chronic spontaneous urticaria; results showed ozureprubart at both Q8W and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback